Arnold W C
Pediatrics. 1984 Nov;74(5):872-5.
The effect of a combination of metolazone (0.2 to 0.4 mg/kg/d) and furosemide (2 to 4 mg/kg/d) in achieving a natriuresis and diuresis was measured in 14 children during 22 episodes of edema resistant to furosemide alone. Urinary volume increased from 24 +/- 14 mL/kg/d for patients receiving furosemide to 51 mL/kg/d with combined diuretic therapy (P less than .01), and sodium excretion increased from 34 +/- 5 mEq/d to 155 +/- 176 mEq/d (P less than .01). Two children with severe hypoalbuminemia (serum albumin level less than 1.5 g/dL) and normal renal function, and five children with chronic renal insufficiency (71%) did not respond to combined diuretic therapy. The combination of furosemide and metolazone offers a useful and effective oral therapy in most children with edema resistant to furosemide. Children with chronic renal insufficiency and furosemide-resistant edema did not respond to combination diuretic therapy.
在14名儿童的22次仅用速尿治疗无效的水肿发作期间,测定了美托拉宗(0.2至0.4毫克/千克/天)和速尿(2至4毫克/千克/天)联合使用实现钠利尿和利尿的效果。接受速尿治疗的患者尿量从24±14毫升/千克/天增加到联合利尿剂治疗时的51毫升/千克/天(P<0.01),钠排泄量从34±5毫当量/天增加到155±176毫当量/天(P<0.01)。两名严重低白蛋白血症(血清白蛋白水平低于1.5克/分升)且肾功能正常的儿童,以及五名慢性肾功能不全儿童(71%)对联合利尿剂治疗无反应。速尿和美托拉宗联合使用为大多数对速尿治疗无效的水肿儿童提供了一种有用且有效的口服治疗方法。慢性肾功能不全且速尿抵抗性水肿的儿童对联合利尿剂治疗无反应。